Comparison of 1-and 2-year screening intervals for women undergoing screening mammography

被引:31
作者
Wai, ES
D'yachkova, Y
Olivotto, IA
Tyldesley, S
Phillips, N
Warren, LJ
Coldman, AJ
机构
[1] Vancouver Isl Ctr, BCanc Agcy, Radiat Therapy Program, Victoria, BC V8R 6V5, Canada
[2] Screening Mammog Program BC, Vancouver, BC V5Z 1G1, Canada
[3] Vancouver Ctr, BC Canc Agcy, Radiat Therapy Program, Vancouver, BC V5Z 4E6, Canada
[4] British Columbia Canc Agcy, Populat & Prevent Oncol Program, Vancouver, BC V5Z 1G1, Canada
关键词
mammography; screening frequency; screening interval; breast cancer survival;
D O I
10.1038/sj.bjc.6602393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We compared the long-term impact of 1- and 2-year screening mammography intervals using prognostic, screening, and outcome information for women aged 50-74 years obtained from the Screening Mammography Program of British Columbia in two time periods, prior to 1997 (policy of annual mammography) and after 1997 (biennial mammography). Survival was estimated for both periods using a prognostic model and the expected rate of interval and screen-detected cancers. The likelihood of a screen-detected cancer with annual screening was 2.32 per thousand screens and with biennial screening was 3.32 per thousand screens. The prognostic profile of screen-detected cancers was better than that of interval cancers. Among both screen-detected and interval cancers, the prognostic profiles with annual and biennial screening were similar. The estimated breast cancer-specific survival rates for women undergoing annual and biennial screening mammography were 95.2 and 94.6% at 5 years, and 90.4 and 89.2% at 10 years, respectively. Annual compared to biennial mammography was associated with a 1.2% increase in the estimated 10-year breast cancer-specific survival for women aged 50-74 years, diagnosed with invasive breast cancer after screening programme attendance.
引用
收藏
页码:961 / 966
页数:6
相关论文
共 34 条
[1]   14 years of follow-up from the Edinbugh randomised trial of breast-cancer screening [J].
Alexander, FE ;
Anderson, TJ ;
Brown, HK ;
Forrest, APM ;
Hepburn, W ;
Kirkpatrick, AE ;
Muir, BB ;
Prescott, RJ ;
Smith, A .
LANCET, 1999, 353 (9168) :1903-1908
[2]  
Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO
[3]  
2-#
[4]  
Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167
[5]  
Blamey RW, 2002, EUR J CANCER, V38, P1458
[6]   Screening interval breast cancers: Mammographic features and prognostic factors [J].
Burrell, HC ;
Sibbering, DM ;
Wilson, ARM ;
Pinder, SE ;
Evans, AJ ;
Yeoman, LJ ;
Elston, CW ;
Ellis, IO ;
Blamey, RW ;
Robertson, JFR .
RADIOLOGY, 1996, 199 (03) :811-817
[7]   Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ [J].
Carlson, KL ;
Helvie, MA ;
Roubidoux, MA ;
Kleer, CG ;
Oberman, HA ;
Wilson, TE ;
Pollak, EW ;
Rochester, AB .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (02) :313-317
[8]   ANALYSIS OF BREAST-CANCER MORTALITY AND STAGE DISTRIBUTION BY AGE FOR THE HEALTH-INSURANCE PLAN CLINICAL-TRIAL [J].
CHU, KC ;
SMART, CR ;
TARONE, RE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (14) :1125-1132
[9]   ANALYSIS OF THE TEMPORAL PATTERNS OF BENEFITS IN THE HEALTH-INSURANCE-PLAN-OF-GREATER-NEW-YORK TRIAL BY STAGE AND AGE [J].
CHU, KC ;
CONNOR, RJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (10) :1039-1049
[10]   Ten-year risk of false positive screening mammograms and clinical breast examinations [J].
Elmore, G ;
Barton, MB ;
Moceri, VM ;
Polk, S ;
Arena, PJ ;
Fletcher, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (16) :1089-1096